Related Experiment Videos
Treatment of bacterial peritonitis
S Puleo1, B Scilletta, T Guastella
1First Clinic of Surgery and Surgical Therapy, Catania University, Italy.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|August 1, 1988
Summary
Cefotetan, a cephamycin antibiotic, effectively treats intra-abdominal infections in surgical patients. This study found a 94% success rate, supporting its use in moderate to severe cases.
Area of Science:
- Infectious Diseases
- Pharmacology
- Surgical Infections
Background:
- Cefotetan is a semi-synthetic cephamycin antibiotic with broad-spectrum activity against aerobic and anaerobic bacteria.
- Intra-abdominal infections are common in surgical patients and require effective antimicrobial therapy.
Purpose of the Study:
- To evaluate the therapeutic efficacy of cefotetan in the treatment of intra-abdominal infections.
- To assess cefotetan's effectiveness as both monotherapy and combination therapy.
Main Methods:
- A retrospective analysis of 107 surgical patients with intra-abdominal infections treated with cefotetan over three years.
- Patients received either cefotetan combined with aminoglycosides (35 patients) or cefotetan monotherapy (72 patients).
Main Results:
- A high success rate of 94% was achieved with cefotetan-based antibiotic therapy across all patient groups.
- Good clinical outcomes were observed even in severely ill, high-risk patients receiving combination therapy.
Conclusions:
- Cefotetan demonstrates significant therapeutic value in managing moderate to severe intra-abdominal infections in surgical patients.
- Both cefotetan monotherapy and combination therapy show high efficacy, supporting its clinical use.